Limiglidole is a antihyperglycaemic drug candidate. Limiglidole exhibits antiplatelet activity 2-fold exceeded activity of antiplatelet agent acetylsalicylic acid in the mouse model of systemic collagen-epinephrine thrombosis. Limiglidole significantly reduced the relative and mean area of blood clots in the sections of mouse lungs. References: Kucheryavenko AF, Spasov AA, Smirnov AV. Antithrombotic Activity of a New Hypoglycemic Compound Limiglidole in Mouse Model of Cell Thrombosis. Bull Exp Biol Med. 2015 May;159(1):41-3. doi: 10.1007/s10517-015-2885-x. Epub 2015 Jun 2. PubMed PMID: 26033587.

纯度：≥98%

CAS：64644-54-8